Franco Nolè
Istituti di Ricovero e Cura a Carattere Scientifico · 298 works · 14,157 citations · h-index 51
Top works
- Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
- Chemotherapy Is More Effective in Patients with Breast Cancer Not Expressing Steroid Hormone Receptors
- Trastuzumab-Induced Cardiotoxicity: Clinical and Prognostic Implications of Troponin I Evaluation
- Totally implantable central venous access ports for long-term chemotherapy A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days
- Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data
- High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxel
- Very young women (<35 years) with operable breast cancer: features of disease at presentation
- Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial
- Clinical Relevance of HER2 Overexpression/Amplification in Patients With Small Tumor Size and Node-Negative Breast Cancer
- Addition of radium-223 to abiraterone acetate and prednisone or prednisolone in patients with castration-resistant prostate cancer and bone metastases (ERA 223): a randomised, double-blind, placebo-controlled, phase 3 trial
- Response to primary chemotherapy in breast cancer patients with tumors not expressing estrogen and progesterone receptors
- Rucaparib or Physician’s Choice in Metastatic Prostate Cancer
- Breast carcinoma in elderly women
- Double-blind, randomised, controlled study of the efficacy and tolerability of palonosetron plus dexamethasone for 1 day with or without dexamethasone on days 2 and 3 in the prevention of nausea and vomiting induced by moderately emetogenic chemotherapy
- A meta-analysis of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 discordance between primary breast cancer and metastases
- Variation of circulating tumor cell levels during treatment of metastatic breast cancer: prognostic and therapeutic implications
- Prediction of response to primary chemotherapy for operable breast cancer
- Carboplatin in patients with advanced colorectal cancer pretreated with fluoropyrimidines
- Should liver metastases of breast cancer be biopsied to improve treatment choice?
- Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial